Ozonation of antidepressant fluoxetine and its metabolite product norfluoxetine: Kinetics, intermediates and toxicity

Chemical Engineering Journal

Volumn 316, Issue , 2017, Pages 951-963

  Zhao, Yue ^a   Yu, Gang ^a   Chen, Siyu ^a   Zhang, Siyu ^b   Wang, Bin ^a   Huang, Jun ^a   Deng, Shubo ^a   Wang, Yujue ^a  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF APPLIED ECOLOGY   (China)

Author keywords

Fluoxetine; Intermediates; NorfluoxetineNorfluoxitine; Ozonation; Small molecular byproducts; Toxicity

Indexed keywords

ALDEHYDES; BYPRODUCTS; CARBONYLATION; METABOLITES; ORGANIC CARBON; OZONIZATION; PROTONATION; TOXICITY;

DEPROTONATED FORM; FLUOXETINE; INTERMEDIATES; NORFLUOXETINENORFLUOXITINE; ORDERS OF MAGNITUDE; OXIDATION PRODUCTS; OZONATION PRODUCTS; TOXICITY EVOLUTION;

OZONE;

EID: 85013224732     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2017.02.032     Document Type: Article

References (58)

1. [1] Daughton, C.G., Ternes, T.A., Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Persp. 107 (1999), 907–938.
2. [2] Prasse, C., Wagner, M., Schulz, R., Ternes, T.A., Oxidation of the antiviral drug acyclovir and its biodegradation product carboxy-acyclovir with ozone: kinetics and identification of oxidation products. Environ. Sci. Technol. 46 (2012), 2169–2178.
3. [3] Pastrana-Martínez, L.M., Faria, J.L., Doña-Rodríguez, J.M., Fernández-Rodríguez, C., Silva, A.M.T., Degradation of diphenhydramine pharmaceutical in aqueous solutions by using two highly active TiO2photocatalysts: operating parameters and photocatalytic mechanism. Appl. Catal. B-Environ. 113 (2012), 221–227.
4. [4] Jones, O.A., Lester, J.N., Voulvoulis, N., Pharmaceuticals: a threat to drinking water?. Trends Biotechnol. 23 (2005), 163–167.
5. [5] Valcarcel, Y., Alonso, S.G., Rodriguez-Gil, J.L., Maroto, R.R., Gil, A., Catala, M., Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in river- and drinking-water of the Madrid Region in Spain. Chemosphere 82 (2011), 1062–1071.
6. [6] Kumar, A., Xagoraraki, I., Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Sci. Total Environ. 408 (2010), 5972–5989.
7. [7] Yuan, F., Hu, C., Hu, X.X., Qu, J.H., Yang, M., Degradation of selected pharmaceuticals in aqueous solution with UV and UV/H2O2. Water Res. 43 (2009), 1766–1774.
8. [8] Silva, L.J.G., Lino, C.M., Meisel, L.M., Pena, A., Selective serotonin re-uptake inhibitors (SSRIs) in the aquatic environment: an ecopharmacovigilance approach. Sci. Total Environ. 437 (2012), 185–195.
9. [9] Schultzt, M.M., Furlong, E.T., Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 80 (2008), 1756–1762.
10. [10] Alvarino, T., Suarez, S., Katsou, E., Vazquez-Padin, J., Lema, J.M., Omil, F., Removal of PPCPs from the sludge supernatant in a one stage nitritation/anammox process. Water Res. 68 (2015), 701–709.
11. [11] Gomez, D.A.M., Baca, S., Walsh, E.J., Lethal and sublethal effects of selected PPCPs on the freshwater rotifer, Plationus patulus. Environ. Toxicol. Chem. 34 (2015), 913–922.
12. [12] Johnson, D.J., Sanderson, H., Brain, R.A., Wilson, C.J., Bestari, K.T., Solomon, K.R., Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Regul. Toxicol. Pharm. 42 (2005), 313–323.
13. [13] Kwon, J.W., Armbrust, K.L., Laboratory persistence and fate of fluoxetine in aquatic environments. Environ. Toxicol. Chem. 25 (2006), 2561–2568.
14. [14] Conley, J.M., Symes, S.J., Schorr, M.S., Richards, S.M., Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 73 (2008), 1178–1187.
15. [15] Hedgespeth, M.L., Sapozhnikova, Y., Pennington, P., Clum, A., Fairey, A., Wirth, E., Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina. Sci. Total Environ. 437 (2012), 1–9.
16. [16] Schultz, M.M., Furlong, E.T., Kolpin, D.W., Werner, S.L., Schoenfuss, H.L., Barber, L.B., Blazer, V.S., Norris, D.O., Vajda, A.M., Antidepressant pharmaceuticals in two US effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 44 (2010), 1918–1925.
17. [17] Rosal, R., Rodriguez, A., Perdigon-Melon, J.A., Petre, A., Garcia-Calvo, E., Gomez, M.J., Aguera, A., Fernandez-Alba, A.R., Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 44 (2010), 578–588.
18. [18] Wert, E.C., Rosario-Ortiz, F.L., Snyder, S.A., Effect of ozone exposure on the oxidation of trace organic contaminants in wastewater. Water Res. 43 (2009), 1005–1014.
19. [19] Hollender, J., Zimmermann, S.G., Koepke, S., Krauss, M., McArdell, C.S., Ort, C., Singer, H., von Gunten, U., Siegrist, H., Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ. Sci. Technol. 43 (2009), 7862–7869.
20. [20] Ternes, T.A., Stuber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, M., Teiser, B., Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Res. 37 (2003), 1976–1982.
21. [21] von Sonntag, C., von Gunten, U., Chemistry of Ozone in Water and Wastewater Treatment: From Basic Principles to Applications. 2012, International Water Association.
22. [22] Beltran, F.J., Aguinaco, A., Garcia-Araya, J.F., Mechanism and kinetics of sulfamethoxazole photocatalytic ozonation in water. Water Res. 43 (2009), 1359–1369.
23. [23] Dantas, R.F., Canterino, M., Marotta, R., Sansa, C., Esplugas, S., Andreozzi, R., Bezafibrate removal by means of ozonation: primary intermediates, kinetics, and toxicity assessment. Water Res. 41 (2007), 2525–2532.
24. [24] Esplugas, S., Bila, D.M., Krause, L.G.T., Dezotti, M., Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J. Hazard. Mater. 149 (2007), 631–642.
25. [25] Trogolo, D., Mishra, B.K., Heeb, M.B., von Gunten, U., Arey, J.S., Molecular mechanism of NDMA Formation from N, N-Dimethylsulfamide during ozonation: quantum chemical insights into a bromide-catalyzed pathway. Environ. Sci. Technol. 49 (2015), 4163–4175.
26. [26] Kuang, J.M., Huang, J., Wang, B., Cao, Q.M., Deng, S.B., Yu, G., Ozonation of trimethoprim in aqueous solution: identification of reaction products and their toxicity. Water Res. 47 (2013), 2863–2872.
27. [27] Benner, J., Ternes, T.A., Ozonation of metoprolol: elucidation of oxidation pathways and major oxidation products. Environ. Sci. Technol. 43 (2009), 5472–5480.
28. [28] Lajeunesse, A., Blais, M., Barbeau, B., Sauve, S., Gagnon, C., Ozone oxidation of antidepressants in wastewater -treatment evaluation and characterization of new by-products by LC-QToFMS. Chem. Cent. J., 7, 2013.
29. [29] Liu, C., Nanaboina, V., Korshin, G., Spectroscopic study of the degradation of antibiotics and the generation of representative EfOM oxidation products in ozonated wastewater. Chemosphere 86 (2012), 774–782.
30. [30] Blum, D.J.W., Speece, R.E., Quantitative structure-activity-relationships for chemical toxicity to environmental bacteria. Ecotox. Environ. Safe. 22 (1991), 198–224.
31. [31] Skoumal, M., Cabot, P.L., Centellas, F., Arias, C., Rodriguez, R.M., Garrido, J.A., Brillas, E., Mineralization of paracetamol by ozonation catalyzed with Fe2+, Cu2+and UVA light. Appl. Catal. B-Environ. 66 (2006), 228–240.
32. [32] Munger, J.W., Collett, J., Daube, B., Hoffmann, M.R., Fogwater chemistry at riverside, California. Atmos. Environ. B-Urb. 24 (1990), 185–205.
33. [33] Li, X., Wang, Y.J., Yuan, S., Li, Z.X., Wang, B., Huang, J., Deng, S.B., Yu, G., Degradation of the anti-inflammatory drug ibuprofen by electro-peroxone process. Water Res. 63 (2014), 81–93.
34. [34] Lajeunesse, A., Gagnon, C., Gagne, F., Louis, S., Cejka, P., Sauve, S., Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment – evidence of biological effects. Chemosphere 83 (2011), 564–571.
35. [35] Aghaeinejad-Meybodi, A., Ebadia, A., Shafiei, S., Khataee, A.R., Rostampoura, M., Modeling and optimization of antidepressant drug Fluoxetine removal in aqueous media by ozone/H2O2process: comparison of central composite design and artificial neural network approaches. J. Taiwan Inst. Chem. E. 48 (2015), 40–48.
36. [36] Mendez-Arriaga, F., Otsu, T., Oyama, T., Gimenez, J., Esplugas, S., Hidaka, H., Serpone, N., Photooxidation of the antidepressant drug Fluoxetine (Prozac (R)) in aqueous media by hybrid catalytic/ozonation processes. Water Res. 45 (2011), 2782–2794.
37. [37] Benner, J., Ternes, T.A., Ozonation of propranolol: formation of oxidation products. Environ. Sci. Technol. 43 (2009), 5086–5093.
38. [38] Zhao, Y., Kuang, J.M., Zhang, S.Y., Li, X., Wang, B., Huang, J., Deng, S.B., Wang, Y.J., Yu, G., Ozonation of indomethacin: kinetics, mechanisms and toxicity. J. Hazard. Mater. 323 (2017), 460–470.
39. [39] Bader, H., Hoigne, J., Determination of ozone in water by the indigo method. Water Res. 15 (1981), 449–456.
40. [40] Yu, X., Zuo, J.N., Tang, X.Y., Li, R.X., Li, Z.X., Zhang, F., Toxicity evaluation of pharmaceutical wastewaters using the alga Scenedesmus obliquus and the bacterium Vibrio fischeri. J. Hazard. Mater. 266 (2014), 68–74.
41. [41] Snyder, S.A., Adham, S., Redding, A.M., Cannon, F.S., De Carolis, J., Oppenheimer, J., Wert, E.C., Yoon, Y., Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202 (2007), 156–181.
42. [42] https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf.
43. [43] Borowska, E., Bourgin, M., Hollender, J., Kienle, C., McArdell, C.S., von Gunten, U., Oxidation of cetirizine, fexofenadine and hydrochlorothiazide during ozonation: kinetics and formation of transformation products. Water Res. 94 (2016), 350–362.
44. [44] Lee, C., Schmidt, C., Yoon, J., von Gunten, U., Oxidation of N-nitrosodimethylamine (NDMA) precursors with ozone and chlorine dioxide: kinetics and effect on NDMA formation potential. Environ. Sci. Technol. 41 (2007), 2056–2063.
45. [45] Garcia-Galan, M.J., Anfruns, A., Gonzalez-Olmos, R., Rodriguez-Mozaz, S., Comas, J., UV/H2O2degradation of the antidepressants venlafaxine and O-desmethylvenlafaxine: elucidation of their transformation pathway and environmental fate. J. Hazard. Mater. 311 (2016), 70–80.
46. [46] Bailey, P.S., Ozonation in Organic Chemistry: Nonolefinic Compounds. 1982, Academic Press, New York, 19–25 238-241.
47. [47] Lay, T.H., Bozzelli, J.W., Seinfeld, J.H., Atmospheric photochemical oxidation of benzene: benzene plus OH and the benzene-OH adduct (hydroxyl-2,4-cyclohexadienyl) plus O-2. J. Phys. Chem.-Us. 100 (1996), 6543–6554.
48. [48] Tay, K.S., Rahman, N.A., Bin, M.R., Abas, Characterization of atenolol transformation products in ozonation by using rapid resolution high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Microchem. J. 99 (2011), 312–326.
49. [49] Bailey, P.S., The reactions of ozone with organic compounds. Chem. Rev. 58 (1958), 925–1010.
50. [50] Rosal, R., Rodriguez, A., Gonzalo, M.S., Garcia-Calvo, E., Catalytic ozonation of naproxen and carbamazepine on titanium dioxide. Appl. Catal. B-Environ. 84 (2008), 48–57.
51. [51] Valsania, M.C., Fasano, F., Richardson, S.D., Vincenti, M., Investigation of the degradation of cresols in the treatments with ozone. Water Res. 46 (2012), 2795–2804.
52. [52] Chang, J., Chen, Z.L., Wang, Z., Shen, J.M., Chen, Q., Kang, J., Yang, L., Liu, X.W., Nie, C.X., Ozonation degradation of microcystin-LR in aqueous solution: intermediates, byproducts and pathways. Water Res. 63 (2014), 52–61.
53. [53] Beltran, F.J., Aguinaco, A., Garcia-Araya, J.F., Oropesa, A.L., Ozone and photocatalytic processes to remove the antibiotic sulfamethoxazole from water. Water Res. 42 (2008), 3799–3808.
54. [54] Orge, C.A., Faria, J.L., Pereira, M.F.R., Removal of oxalic acid, oxamic acid and aniline by a combined photolysis and ozonation process. Environ. Technol. 36 (2015), 1075–1083.
55. [55] Faria, P.C.C., Orfao, J.J.M., Pereira, M.F.R., Activated carbon catalytic ozonation of oxamic and oxalic acids. Appl. Catal. B-Environ. 79 (2008), 237–243.
56. [56] Abellan, M.N., Gebhardt, W., Schroder, H.F., Detection and identification of degradation products of sulfamethoxazole by means of LC/MS and -MS(n) after ozone treatment. Water Sci. Technol. 58 (2008), 1803–1812.
57. [57] Rosal, R., Gonzalo, M.S., Boltes, K., Leton, P., Vaquero, J.J., Garcia-Calvo, E., Identification of intermediates and assessment of ecotoxicity in the oxidation products generated during the ozonation of clofibric acid. J. Hazard. Mater. 172 (2009), 1061–1068.
58. [58] Gomez-Ramos, M.D., Mezcua, M., Aguera, A., Fernandez-Alba, A.R., Gonzalo, S., Rodriguez, A., Rosal, R., Chemical and toxicological evolution of the antibiotic sulfamethoxazole under ozone treatment in water solution. J. Hazard. Mater. 192 (2011), 18–25.